Endothelium-derived contracting factors contribute to endothelial dysfunction in aging, hypertension, and diabetes, which can potentially be mitigated by TP-receptor antagonists.
No takes yet. Share an insight, caveat, or question.
TP-receptor antagonists may mitigate endothelial dysfunction in aging, hypertension, and diabetes; leaves open clinical translation.
Vanhoutte et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: